IMMUCELL CORP /DE/ Income Statement
ICCC|10 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 10 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$26M
FY2025
Gross Profit
$8M
30.0% gross margin
Operating Income
-$2M
FY2025
Net Income
-$2M
FY2025
IMMUCELL CORP /DE/ reported $26M in revenue and $2M in net loss for FY2025. Revenue has grown at a 13.5% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Conservative debt: Debt-to-equity ratio of 0.27
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.5M | $17.5M | $18.6M | $9.5M | $10.2M | $6.0M | $5.4M | $5.1M | $4.4M | $4.5M |
| Cost of Revenue | $18.6M | $13.6M | $10.9M | $4.1M | $4.0M | $2.9M | $2.3M | $2.3M | $2.1M | $2.1M |
| Gross Profit | $7.9M | $3.9M | $7.6M | $5.4M | $6.3M | $3.1M | $3.1M | $2.8M | $2.3M | $2.4M |
| SG&A Expense | $2.2M | $2.1M | $2.3M | $1.5M | $1.3M | $939.2K | $918.4K | $856.6K | $849.1K | $872.5K |
| R&D Expense | $3.9M | $4.4M | $4.5M | $1.2M | $1.2M | $1.2M | $917.6K | $1.7M | $1.5M | $1.6M |
| Operating Income | -$1.6M | -$5.7M | -$2.3M | $890.2K | $2.1M | -$19.6K | $245.0K | -$632.7K | -$690.3K | -$529.9K |
| Interest Expense | - | - | $348.5K | - | - | - | - | - | - | - |
| Income Tax | $10.1K | $4.6K | $7.7K | $249.9K | $850.3K | $87.9K | $102.6K | -$287.2K | -$298.7K | -$212.0K |
| Net Income | -$2.2M | -$5.8M | -$2.5M | $508.4K | $1.2M | $117.4K | $89.5K | -$409.5K | -$384.7K | -$216.5K |
| EPS (Basic) | -$0.26 | -$0.75 | -$0.32 | $0.12 | $0.40 | $0.04 | $0.03 | -$0.14 | -$0.13 | -$0.07 |
| EPS (Diluted) | -$0.26 | -$0.75 | -$0.32 | $0.12 | $0.38 | $0.04 | $0.03 | -$0.14 | -$0.13 | -$0.07 |
| Shares Outstanding | 9.0M | 7.8M | 7.7M | 4.8M | 3.1M | 3.1M | 3.1M | 3.0M | 3.0M | 3.0M |
| Gross Margin | 30.0% | 22.1% | 41.2% | 56.8% | 61.1% | 50.9% | 56.7% | 55.0% | 52.5% | 53.2% |
| Operating Margin | -6.2% | -32.9% | -12.4% | 9.3% | 20.8% | -0.3% | 4.5% | -12.4% | -15.7% | -11.8% |
| Profit Margin | -8.1% | -33.1% | -13.4% | 5.3% | 11.9% | 1.9% | 1.7% | -8.0% | -8.8% | -4.8% |